BlueCrow Capital

BlueCrow Capital is a venture capital firm established in 2010 and headquartered in Lisboa, Portugal. The firm focuses on investing in a diverse range of sectors, including robotics and information and communications technology (ICT), medical technology (medtech), biotechnology, sustainable food, laser technology, industrial applications, and agriculture. BlueCrow Capital aims to support innovative companies that are poised for growth and contribute to advancements in these key industries.

António Mello Campello

Co-Founder and Partner

Bernardo Meira

Co-Founder and Partner

Calheiros de Menezes, Duarte

Partner and Fund Manager

10 past transactions

Bighub

Seed Round in 2025
Bighub is a marketplace integration technology and sales accelerator that synchronizes with over 30 marketplaces in a single ecosystem.

Sensei

Series A in 2024
Sensei offers a scalable, seamless store-wide solution that empowers the stores of the future to be check-out and cash free. Through an integrated system of cameras and AI algorithms, Sensei enables a new era of Phygital stores able to capture in-store product data and shoppers’ activities, to offer a wealth of analytics and smooth, frictionless shopping experience.

Maven Pet

Pre Seed Round in 2024
Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Oceano Fresco

Venture Round in 2024
Oceano Fresco develops and produces bivalves varieties with superior performance for shellfish farmers at a competitive cost, respecting environmental sustainability and ensuring consumer safety. They use a multi-disciplinary approach including expertise in molecular biology, genetics, animal physiology, computational biology and intellectual property to select value adding traits to shellfish farmers and contribute to the sustainability and profitability of the aquaculture industry. They work with hatcheries, nurseries and research centers in order to test and validate their solutions and ensure that they suit the specific needs of each customer, in each technical and environmental context.

Tonic App

Series A in 2024
Tonic App S.A. is a technology company based in Porto, Portugal, that has developed a mobile application designed to enhance communication and collaboration among medical professionals. The application supports doctors by enabling messaging, sharing, and archiving of patient cases, as well as facilitating expert consultations and networking opportunities. It serves various stakeholders in the healthcare sector, including hospitals, pharmaceutical companies, and medical associations, to connect medical doctors with their peers and relevant communities. Additionally, the application provides access to essential medical content, allows for the coordination of urgent procedures, and enables discussions on clinical cases. With features like video consultations, prescription tools, and clinical decision support resources, Tonic App aims to improve the efficiency of clinical practices and ultimately enhance patient outcomes. Established in 2016, the company is recognized for its commitment to quality and safety in its clinical algorithms.

KIT-AR

Seed Round in 2024
KIT-AR Ltd is a company based in London, United Kingdom, that specializes in designing and developing integrated industrial augmented reality systems aimed at enhancing manufacturing productivity across various industries, including automotive, aerospace, and electronics. Founded in 2018, KIT-AR focuses on providing solutions that help reduce production errors and improve quality assurance on the shop floor. The company's offerings include KIT-ASSIST, which delivers specialist knowledge through a heads-up display; KIT-SMART, a set of intelligent modules that monitor the working environment and worker activity; KIT-BUILD, which manages work instructions; and KIT-INSIGHT, which provides insights into productivity and efficiency. By connecting and empowering shop floor employees with timely information and automated quality checks, KIT-AR enables manufacturers to minimize unplanned downtime and achieve higher accuracy in their operations.

Paynest

Seed Round in 2023
At Paynest, we are simplifying employee finance. We are reshaping how companies operate and engage with their employees. With flexible, simple, and innovative solutions, we enable each member of your company to focus on their true strengths. We empower leaders by bringing simplicity into their journey, offering an integrated platform of solutions crafted to effortlessly streamline their daily operations: expense management, compensation on-demand, financial coaching, and more. Our team is dedicated to developing new products that are easy to use while championing the digital evolution of time-consuming tasks, making them simpler and more efficient.

PayNest

Seed Round in 2023
PayNest is a payments amalgamator, which was created with the core mission of digitizing cash collection in the Middle East.

Ophiomics

Series A in 2023
Ophiomics S.A. is a clinical-stage biotech company based in Lisbon, Portugal, specializing in the development of diagnostic products and services for liver cancer. Established in 2015, Ophiomics focuses on integrating bioinformatics, artificial intelligence, and genomics to enhance diagnostic and prognostic capabilities in oncology. The company is ISO 13485 and ISO 9001 certified, ensuring adherence to high-quality standards in its operations. Its product pipeline encompasses various stages of development, including pre-clinical programs and those undergoing clinical validation. Ophiomics aims to improve early detection of liver cancer through biomarker-based diagnostic devices that combine molecular signatures with clinical parameters in predictive algorithms, ultimately assisting healthcare providers in treatment selection and clinical follow-up for better patient outcomes.

Oceano Fresco

Venture Round in 2019
Oceano Fresco develops and produces bivalves varieties with superior performance for shellfish farmers at a competitive cost, respecting environmental sustainability and ensuring consumer safety. They use a multi-disciplinary approach including expertise in molecular biology, genetics, animal physiology, computational biology and intellectual property to select value adding traits to shellfish farmers and contribute to the sustainability and profitability of the aquaculture industry. They work with hatcheries, nurseries and research centers in order to test and validate their solutions and ensure that they suit the specific needs of each customer, in each technical and environmental context.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.